skip to Main Content

LED Medical Diagnostics’ VELscope® Vx Receives Eighth Consecutive Cellerant “Best of Class” Technology Award for 2018

  • September 26, 2018
  • News Releases

Vancouver, BC – September 26, 2018 – LED Medical Diagnostics Inc. (“LED Medical” or “the Company”), has proudly announced that its VELscope® Vx Enhanced Oral Assessment System, manufactured by its subsidiary LED Dental Inc. (“LED Dental”), has received the Cellerant “Best of Class” Technology Award for the eighth consecutive year. The VELscope Vx has once again been designated as the leading device for the “oral screening” category, continuing to be recognized as the vanguard technology in the space.

The VELscope Vx utilizes tissue fluorescence technology to serve as an adjunct to the traditional comprehensive oral examination, aiding in the enhanced visualization of a variety of oral mucosal abnormalities, including oral cancer and pre-malignant dysplasia. Clinicians can incorporate the VELscope technology into their existing oral screening protocol as an additional tool to help ensure that areas of concern are visualized, even those that may not be apparent or even visible with the naked eye.

“Receiving the Cellerant Best of Class Award is an honor due to the rigorous product review process and the recognized clinical expertise of the panel members,” stated Wayne Rees, vice president of VELscope imaging for LED Dental. “We are proud that a group of respected dental thought leaders continues to see the value of the VELscope technology in the modern dental practice over such a sustained period.”

The Cellerant “Best of Class” Technology Award is one of the most prestigious dental industry honors recognizing innovation from manufacturers and service providers. “Best of Class” honorees are chosen by a panel of leading voices in dental technology that come together each year to discuss, debate and decide which products merit recognition.

“We see the pace of innovation accelerating in dentistry, which is a shift from our assessment just a few years ago,” said Dr. John Flucke, one of Cellerant’s Chief Development Officers and a Best of Class panel member. “Selection as a ‘Best of Class’ winner recognizes manufacturers that develop technologies that are truly exceptional.”

Dr. David Gane, CEO of LED Medical concluded, “Our VELscope team continually strives to deliver innovations that set our technology apart from our competitors. Receiving an eighth consecutive Best of Class award reinforces the efforts of our entire team in delivering class-leading adjunctive oral screening capabilities to the global dental market.”

The Best of Class Technology Award winners will be showcased at the 2018 ADA Annual Meeting in Honolulu from October 18–22. Dental professionals will have the unique opportunity to experience the Best of Class technologies, including the VELscope Vx, first-hand at the ADA meeting, as well as hear the panel members lecture on these products at the Digital Future of Dentistry Technology Expo.

For more information on the VELscope Vx, please visit www.velscope.com.

About LED Medical Diagnostics Inc.

LED Medical Diagnostics Inc. is a dental imaging technology provider focused on delivering state-of-the-art imaging software and systems. Through its wholly-owned subsidiaries LED Dental Inc., LED Dental Ltd., and Apteryx, Inc., LED Medical has provided dentists and oral health specialists with advanced diagnostic imaging products and software for over 20 years. LED’s proprietary technologies include the VELscope Vx Enhanced Oral Assessment and TUXEDO Intraoral Sensors, in addition to Apteryx’s XrayVision, XVWeb and XrayVision DCV imaging software solutions.

Backed by an experienced leadership team and dedicated to a higher level of service and support, LED is committed to providing dental practitioners with the best technology available by identifying and adding leading products to its growing portfolio. The Company is currently listed on the TSX-V under the symbol LMD, the OTCQB under the symbol LEDIF, as well as the Frankfurt Stock Exchange under the symbol LME.

About the Cellerant Best of Class Technology Award

Since the inaugural presentation in 2009, the Best of Class Technology Awards have grown to occupy a unique space in dentistry by creating awareness in the community of manufacturers that are driving the discussion as to how practices will operate now and in the future.

The selection process relies on an expert panel of dentists recognized as thought leaders and educators. It includes Dr. Paul Feuerstein, Dr. John Flucke, Dr. Marty Jablow, Dr. Pamela Maragliano-Muniz, Dr. Chris Salierno, and Dr. Lou Shuman. Over the course of each year, the panel members seek out and conduct research on potentially practice-changing technologies, with deliberations on nominees and final voting taking place in February. Panelists are precluded from voting in any category where they have consulting relationships. The entire selection process is conducted and managed on a not-for-profit basis.

For more information on the Cellerant Best of Class Awards and the 2018 Award Winners, go to www.cellerantconsulting.com/bestofclass.

About Cellerant Consulting Group

Founded and led by CEO Dr. Lou Shuman, DMD, CAGS, Cellerant provides strategic dental market insights, clinical expertise, implementation resources and support to accelerate growth for client dental companies. Cellerant services include new concept incubation, clinical product evaluation, product development, continuing education program development and CE sponsorship, strategic branding and marketing, online marketing, lead generation and dental media relations management. As an orthodontist and former owner of a 10-doctor multi-specialty private group practice, Dr. Shuman guides clients to offer products that engage dental customers and provide sustained differentiation. Cellerant operates under a unique model that merges leading voices in clinical product evaluation and strategic partner companies to provide a menu of services from one easily accessible network.

LED Medical Diagnostics

Media Contacts:

LED Dental
Chris Koch
Phone: 678.293.9413
Email: chris.koch@leddental.com

Corporate Contact:

LED Medical
David Gane, CEO
Phone: 604.434.4614, ext. 227
Email: david.gane@leddental.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward Looking Statements

This press release contains statements which, to the extent that they are not recitations of historical fact, may constitute forward-looking information under applicable Canadian securities legislation that involve risks and uncertainties. Such forward-looking statements or information include statements regarding, but not limited to the Company’s future growth strategy, its distribution strategy and product offerings, potential expansion of the Company’s technology to other medical applications or markets, or the potential introduction of new technologies by the Company. Persons reading this press release are cautioned that such statements or information are only predictions, and that the Corporation’s actual future results or performance may be materially different. Factors that could cause actual events or results to differ materially from those suggested by these forward-looking statements include, but are not limited to competition risks, distributor risks, product development risks such as regulatory, design, intellectual property and other factors described in the Corporation’s reports filed on SEDAR including its Annual Information Form and financial report for the year ended December 31, 2017.  These and other factors should be considered carefully and readers should not place undue reliance on such forward-looking information. All forward-looking statements made in this press release are qualified by this cautionary statement and there can be no assurance that actual results or developments anticipated by the Company will be realized. The Company disclaims any intention or obligation to update or revise forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.

Back To Top